Cancer News and Research

Latest Cancer News and Research

2010 Driven to Quit Challenge: 11 tobacco-free Ontarians declared winners

Eleven newly tobacco-free Ontarians will be declared winners of the 2010 Driven to Quit Challenge next week. More than 28,800 showed their drive and pledged to quit their tobacco use for their chance to win a new Ford Escape hybrid, one of two $5,000 vacation getaways and $15,000 in MasterCard gift cards. Winners and their support buddies will be on site with guest speakers and their prizes, including the new hybrid vehicle.

19 Apr 2010

Valedictory Symposium to celebrate Professor David Taylor's contribution to Obstetrics and Gynaecology

Medical experts from across the UK are gathering at the University of Leicester on Friday 23rd April in a Valedictory Symposium to celebrate the work of Professor David Taylor.

19 Apr 2010

Weeklong, 60-mile breast cancer fundraising walk in Spain

For A Cause, has been organizing breast cancer fundraising walks since 2001. This Mother's Day, the unofficial start to the breast cancer walking season, tens of thousands of women will take to the streets to raise awareness and funds for breast cancer organizations.

19 Apr 2010

Pivotal preclinical data of YM BioSciences' CYT387 JAK1/2 inhibitor pre-published in Blood

YM BioSciences Inc., announced the pre-publication of pivotal preclinical data for CYT387, the company's highly selective and potent JAK1/2 inhibitor, currently in a Phase I/II trial for myelofibrosis.

19 Apr 2010

Mylan Pharmaceuticals introduces 50 mg and 200 mg Clozapine Tablets USP

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Clozapine Tablets USP, 50 mg and 200 mg.

19 Apr 2010

Sentry Air Systems announces equipment compliance with OSHA's hexavalent chromium regulation

The Occupational Health and Safety Administration (OSHA) is enforcing strict regulations regarding worker exposure to hexavalent chromium in several industries. Hexavalent chromium, a volatized and oxidized form of chromium, has been identified as a carcinogen. OSHA has subsequently established stringent regulations for workers who are potentially exposed to it in the general, construction, shipyard, and marine terminal industries.

19 Apr 2010

Skin cancer screening event to highlight need for early detection of the disease

MHAs and staff at the House of Assembly will have their skin checked for skin cancer by St. John's dermatologists at an event at Confederation Building, St. John's, on Tuesday April 20, 2010, from 9.30 am to 12.30pm, to raise awareness about the need for early detection of skin cancer.

19 Apr 2010

Encouraging early data from Bellicum Pharmaceuticals' Phase I/II study of BPX-101 for mCRPC

Bellicum Pharmaceuticals, Inc., a company developing therapeutic cancer vaccines, today announced the presentation of interim Phase I/II efficacy data for BPX-101, a novel dendritic cell vaccine for metastatic castrate resistant prostate cancer (mCRPC), in a Late Breaking poster at the American Association for Cancer Research (AACR) 101st Annual Meeting 2010 held in Washington, D.C.

19 Apr 2010

Election to represent professional staff of NYSNA ordered for USW

An election for union representation has been ordered by the National Labor Relations Board for the United Steelworkers to represent 66 professional staff of the New York State Nurses Association. The definition of this bargaining union was stipulated through the NLRB on Apr. 9.

19 Apr 2010

End-of-life care documentation helps in emergency treatment decisions

When Heather Rubesch was a teenager, her aunt died in need of a kidney transplant. In later family discussions, Heather's mother, Linda, expressed some of her views about end-of-life care—for instance, her belief in organ donation.

19 Apr 2010

Phase II study: Hepatitis C patients receiving ANA598 bid plus SOC attain undetectable levels of virus

Anadys Pharmaceuticals, Inc. announced today that 72% of hepatitis C patients receiving ANA598 400 mg twice daily (bid) plus standard of care achieved undetectable levels of virus at week eight in an ongoing Phase II study, compared to 38% of patients receiving placebo plus SOC.

19 Apr 2010

Stanford researchers discover tissue-specific target in pathogen

A tumor-causing maize fungus with the unsavory-sounding name "corn smut" wields different weapons from its genetic arsenal depending on which part of the plant it infects. The discovery by Stanford researchers marks the first time tissue-specific targeting has been found in a pathogen.

19 Apr 2010

Radiolabeled hedgehog can differentiate stem-like cancer cells, identify aggressive tumors

At the American Association for Cancer Research 101st Annual Meeting 2010, scientists and clinicians will present more than 6,300 abstracts dealing with innovative aspects of biology, technology and emerging therapies.

19 Apr 2010

Study reveals increased risk for cancer among Latino populations

New findings from epidemiology and observational studies show an increased risk for cancer among Latino populations, but unique demographic characteristics suggest the problem may be worse than currently known.

19 Apr 2010

New insights into yeast cells may help identify cancer cells and stem cells development: Study

Yeast cells decide whether to have sex with each other within two minutes of meeting, according to new research published today in Nature. One of the authors of the study, from Imperial College London, says the new insights into how yeast cells decide to mate could be helpful for researchers looking at how cancer cells and stem cells develop.

19 Apr 2010

Stallergenes' US phase III clinical trial of Oralair achieves primary endpoint

Stallergenes S.A. today announced the first results of a phase III clinical trial (VO61.08) conducted in the USA on its sublingual grass pollen immunotherapy tablet, Oralair(R).

19 Apr 2010

New p53 knockout rat model improves timelines for carcinogenicity screening

Sigma Life Science, the innovative biological products and services brand of Sigma-Aldrich, today introduced the world's first p53 'knockout' rat model, an important development that is expected to, due to the rat's closer physiological and metabolic similarity to humans, significantly improve timelines for carcinogenicity screening and reduce time to market for therapeutics.

19 Apr 2010

Amgen announces results from pivotal Phase 3 "408" trial of Vectibix

Amgen today announced detailed results from a new biomarker analysis of the pivotal Phase 3 "408" trial of Vectibix® (panitumumab) plus best supportive care compared to BSC alone. The analysis used massively parallel, next-generation sequencing technology to investigate whether mutations in nine genes known to be mutated in colorectal cancer, including the previously unanalyzed exon 3 mutation of the KRAS gene, are predictive of response to Vectibix in metastatic colorectal cancer.

19 Apr 2010

Results of BATTLE Trial presented at AACR 2010

Lung cancer is the number one cause of cancer death in men and women, but huge randomized trials of thousands of patients have either failed completely or shown negligible survival differences.

19 Apr 2010

EORTC 30904 study: Conservative surgery not inferior to radical renal surgery

The latest results from the European Organisation for Research and Treatment of Cancer (EORTC) 30904 study were presented in a plenary session today at the Anniversary European Association of Urology Congress in Barcelona, which showed that conservative surgery is not inferior to radical renal surgery or nephrectomy.

19 Apr 2010

Cancer News and Research

Latest Cancer News and Research

2010 Driven to Quit Challenge: 11 tobacco-free Ontarians declared winners

Valedictory Symposium to celebrate Professor David Taylor's contribution to Obstetrics and Gynaecology

Weeklong, 60-mile breast cancer fundraising walk in Spain

Pivotal preclinical data of YM BioSciences' CYT387 JAK1/2 inhibitor pre-published in Blood

Mylan Pharmaceuticals introduces 50 mg and 200 mg Clozapine Tablets USP

Sentry Air Systems announces equipment compliance with OSHA's hexavalent chromium regulation

Skin cancer screening event to highlight need for early detection of the disease

Encouraging early data from Bellicum Pharmaceuticals' Phase I/II study of BPX-101 for mCRPC

Election to represent professional staff of NYSNA ordered for USW

End-of-life care documentation helps in emergency treatment decisions

Phase II study: Hepatitis C patients receiving ANA598 bid plus SOC attain undetectable levels of virus

Stanford researchers discover tissue-specific target in pathogen

Radiolabeled hedgehog can differentiate stem-like cancer cells, identify aggressive tumors

Study reveals increased risk for cancer among Latino populations

New insights into yeast cells may help identify cancer cells and stem cells development: Study

Stallergenes' US phase III clinical trial of Oralair achieves primary endpoint

New p53 knockout rat model improves timelines for carcinogenicity screening

Amgen announces results from pivotal Phase 3 "408" trial of Vectibix

Results of BATTLE Trial presented at AACR 2010

EORTC 30904 study: Conservative surgery not inferior to radical renal surgery

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in